A dried tofu-supplemented diet affects mRNA expression of inflammatory cytokines in human blood

Journal of Nutritional Science and Vitaminology

Volumn 56, Issue 6, 2010, Pages 396-410

  Tovar, Vivian ^a   Ogura, Mieko ^a   Kobayashi, Ai ^b   Kimura, Sayaka ^b   Saito, Kazunori ^b   Kainuma, Michiko ^b   Yohda, Masafumi ^c   Hasegawa, Setsuo ^c   Mitsuhashi, Masato ^a  

^a Hitachi Chemical Research Center   (United States)

^b Sekino Clinical Pharmacology Clinic   (Japan)

^c TOKYO UNIVERSITY OF AGRICULTURE AND TECHNOLOGY   (Japan)

Author keywords

IL10; IL6; mRNA; TNFSF15; Tofu

Indexed keywords

CYTOKINE; IMMUNOGLOBULIN G; INTERLEUKIN 6; INTERLEUKIN 8; LIPOPOLYSACCHARIDE; MESSENGER RNA; MONOCLONAL ANTIBODY; PHYTOHEMAGGLUTININ P; PROTEIN TNFSF 1; PROTEIN TNFSF 2; T LYMPHOCYTE RECEPTOR; TUMOR NECROSIS FACTOR; UNCLASSIFIED DRUG; ZYMOSAN;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DIET SUPPLEMENTATION; EX VIVO STUDY; FEMALE; HUMAN; KOYU TOFU; LEUKOCYTE; MALE; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SOYBEAN;

ADULT; ANTIBODIES, MONOCLONAL; BIOLOGICAL MARKERS; CYTOKINES; DIETARY SUPPLEMENTS; FEMALE; HUMANS; IMMUNOGLOBULIN G; INFLAMMATION; INFLAMMATION MEDIATORS; LEUKOCYTES; LIPOPOLYSACCHARIDES; MALE; MIDDLE AGED; PHYTOHEMAGGLUTININS; PLANT PREPARATIONS; POLYMERASE CHAIN REACTION; RNA, MESSENGER; SOY FOODS; SOYBEANS; YOUNG ADULT; ZYMOSAN;

EID: 79952766747     PISSN: 03014800     EISSN: 18817742     Source Type: Journal    
DOI: 10.3177/jnsv.56.396     Document Type: Article

References (36)

1. Adlercreutz CH, Goldin BR, Gorbach SL, Hockerstedt KA, Watanabe S, Hamalainen EK, Markkanen MH, Makela TH, Wahala KT, Adlercreutz T. 1995. Soybean phytoestrogen intake and cancer risk. J Nutr 125: 757S-770S.
2. Szkudelska K, Nogowski L. 2007. Genistein-A dietary compound inducing hormonal and metabolic changes. J Steroid Biochem Mol Biol 105: 37-45.
3. Si H, Liu D. 2007. Phytochemical genistein in the regulation of vascular function: new insights. Curr Med Chem 14: 2581-2589.
4. Marini H, Minutoli L, Polito F, Bitto A, Altavilla D, Atteritano M, Gaudio A, Mazzaferro S, Frisina A, Frisina N, Cubrano C, Bonaiuto M, D'Anna R, Cannata ML, Corrado F, Adamo EB, Wilson S, Squadrito F. 2007. Effects of the phytoestrogen genistein on bone metabolism in osteopenic postmenopausal women: a randomized trial. Ann Intern Med 146: 839-847.
5. Hemaisvarya S, Doble M. 2006. Potential synergism of natural products in the treatment of cancer. Phytother Res 20: 239-249.
6. Aggarwal BB, Shishodia S. 2006. Molecular targets of dietary agents of prevention and therapy of cancer. Biochem Pharmacol 71: 1397-1421.
7. Cooke PS, Selvaraj V, Srikanth Y. 2006. Genistein, estrogen receptors, and the acquired immune response. J Nutr 136: 704-708.
8. Blay M, Espinel AE, Delgado MA, Baiges I, Blade C, Arola L, Salvado J. 2009. Isoflavone effect on gene expression profile and biomarkers of inflammation. J Pharm Biomed Anal 51: 382-390.
9. Banerjee S, Li Y, Wang Z, Sarkar FH. 2008. Multi-targeted therapy of cancer by genistein. Cancer Lett 269: 226-242.
10. Szliszka E, Czuba ZP, Jernas K, Krol W. 2008. Dietary flavonoids sensitize HeLa cells to tumor necrosis factorrelated apoptosis-inducing ligan (TRAIL). Int J Mol Sci 9: 56-64.
11. Sakai T, Kogiso M. 2008. Soy isoflavones and immunity. J Med Invest 55: 167-173.
12. Mitsuhashi M, Ogura M, Endo K, Obara K, Izutsu H, Targan SR, Maemura M, Tachikawa D, Shinagawa A. 2008. Ex vivo induction of mRNA in human whole blood as a new platform of drug and dietary supplement development. Pharm Res 25: 1116-1124.
13. Dia VP, Berhow MA, Gonzalez de Mejia E. 2008. Bowman- Birk inhibitor and genistein among soy compounds that synergistically inhibit nitric oxide and prostaglandin E2 pathways in lipopolysaccharide-induced macrophages. J Agric Food Chem 56: 1707-11717.
14. Mitsuhashi M, Targan SR. 2008. Ex vivo simulation of IgG Fc and T-cell receptor functions: an application to inflammatory bowel disease. Inflamm Bowel Dis 14: 1061-1067.
15. Mitsuhashi M, Endo K, Shinagawa A. 2006. Quantification of mRNA in whole blood by assessing recovery of RNA and efficiency of cDNA synthesis. Clin Chem 52: 634-642.
16. Hasegawa S, Kato H, Yamaguchi H, Yohda M, Obara K, Izutsu H, Ogura M, Mitsuhashi M. 2009. Trastuzumabinduced CCL20 and interleukin-8 mRNA in human whole blood ex vivo. Invest New Drugs 27: 579-582.
17. Mitsuhashi M, Cooper A, Ogura M, Shinagawa T, Yano K. 1994. Oligonucleotide probe design-a new approach. Nature 367: 759-761.
18. Holland PM, Abramson RD, Watson R, Gelfand DH. 1991. Detection of specific polymerase chain reaction product by utilizing the 5_----3_ exonuclease activity of Thermus aquaticus DNA polymerase. Proc Natl Acad Sci USA 88: 7276-7280.
19. Morrison TB, Weis JJ, Wittwer CT. 1998. Quantification of low-copy transcripts by continuous SYBR Green I monitoring during amplification. Biotechniques 24: 954-962.
20. Mitsuhashi M, Keller C, Akitaya T. 1992. Gene manipulation on plastic plates. Nature 1357: 519-520.
21. Hamaguchi Y, Aso Y, Shimada H, Mitsuhashi M. 1998. Direct RT-PCR on oligo(dT)-immobilized polypropylene microplates after capturing total mRNA from crude cell lysates. Clin Chem 44: 2256-2263.
22. Mitsuhashi M, Endo K, Obara K, Izutsu H, Ishida T, Chikatsu N, Shinagawa A. 2008. Quantification of drug-induced mRNA in human whole blood ex vivo. Clin Med Blood Disorders 1: 1-11.
23. Kuiper GG, Lemmen JG, Carlsson B, Corton JC, Safe SH, van der Saag PT, van der Burg B, Gustafsson JA. 1998. Interaction of estrogenic chemicals and phytoestrogens with estrogen receptor beta. Endocrinology 139: 4252-4263.
24. Chun OK, Chung S, Claycombe KJ, Song WO. 2008. Serum C-reactive protein concentrations are inversely associated with dietary flavonoid intake in U.S. adults. J Nutr 138: 753-760.
25. Hall W, Vafeiadou K, Hallund J, Bugel S, Koebruick C, Reinmann M, Ferrari M, Branca F, Talbot D, Dadd T, Nilsson M, Dahlman-Wright K, Gustafsson JA, Minihane AM, Williams C. 2005. Soy-isoflavone-enriched foods and inflammatory biomarkers of cardiovascular disease risk in post-menopausal women: interactions with genotype and equol production. Am J Clin Nutr 82: 1260-1268.
26. De Paula ML, Rodrigues DH, Teixeira HC, Barsante MM, Souza MA, Ferreira AP. 2008. Genistein down-modulates pro-inflammatory cytokines and reverses clinical signs of experimental autoimmune encephalomyelitis. Int Immunopharmacol 8: 1291-1297.
27. Yellayi S, Naaz A, Szewczykowski MA, Sato T, Woods JA, Chang J, Segre M, Allred CD, Helferich WG, Cooke PS. 2002. The phytoestrogen genistein induces thymic and immune changes: a human health concern? Proc Natl Acad Sci USA 99: 7616-7621.
28. Yellayi S, Zakrocyzmski MA, Selvaraj V, Valli VE, Ghanta V, Helferich WG, Cooke PS. 2003. The phytoestrogen genistein suppresses cell-mediated immunity in mice. J Endocrinol 176: 267-274.
29. Kang J, Badger TM, Ronis MJJ, Wu X. 2010. Non-isoflavone phytochemicals in soy and their health effects. J Agric Food Chem 58: 8119-8133.
30. Bouic PJ, Lamprecht JH. 1999. Plant sterols and sterolins: a review of their immune-modulating properties. Altern Med Rev 4: 170-177.
31. Fernandes G, Lawrence R, Sun D. 2003. Protective role of n-3 lipids and soy protein in osteoporosis. Prostaglandins Leukot Essent Fatty Acids 68: 361-372.
32. Migone T, Zhang J, Luo X, Zhuang L, Chen C, Hu B, Hong JS, Perry JW, Chen SF, Zhou JX, Cho YH, Ulrich S, Kanakaraj P, Carrell J, Boyd E, Olsen HS, Hu G, Pukac L, Liu D, Ni J, Kim S, Gentz R, Feng P, Moore PA, Ruben SM, Wei P. 2002. TL1A is a TNF-like ligand for DR3 and TR6/DcR3 and functions as a T cell costimulator. Immunity 16: 479-492.
33. Siegel RM, Chan FK, Chun HJ, Leonardo MJ. 2000. The multifaceted role of Fas signaling in immune cell homeostasis and autoimmunity. Nature 1: 469-474.
34. Tan KB, Harrop J, Reddy M, Young P, Terrett J, Emery J, Moore G, Truneh A. 1997. Characterization of a novel TNF-like ligand and recently described TNF ligand and TNF receptor superfamily genes and their constitutive and inducible expression in hematopoietic and nonhematopoietic cells. Gene 204: 35-46.
35. Bull MJ, Williams AS, Macklenburgh Z, Calder CJ, Twohig JP, Elford C, Evans BA, Rowley TF, Slebioda TJ, Taraban VY, Al-Shamkhani A, Wang EC. 2008. The death receptor 3-TNF-like protein 1A pathway drives adverse bone pathology in nflammatory arthritis. J Exp Med 11: 2457-2464.
36. Mansour A, McCarthy B, Schwander SK, Chang V, Kotenko S, Donepudi S, Lee J, Raveche E. 2004. Genistein induces G2 arrest in malignant B cells by decreasing IL10 secretion. Cell Cycle 3: 1597-1605.